Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleophilic cellular proteins and peptides represent a broad chemical class of biological molecules containing electron-rich functional groups, such as the sulfhydryl group of cysteine, the amino group of lysine, and the imidazole group of histidine (PubChem, 2024). These nucleophilic sites are essential for the physiological function of many enzymes, where they often serve as catalytic residues, and for maintaining cellular redox balance through molecules like glutathione (NIH, 2023). In pharmacology, this category is not a single discrete target but rather a collective site of action for electrophilic drugs, such as nitrogen mustards and platinum-based antineoplastics, which form stable covalent bonds with these groups to disrupt cellular processes (StatPearls, 2023). While these interactions are leveraged to inhibit rapid cell division in cancer, the inherent lack of specificity across the proteome leads to significant off-target effects and safety concerns, including secondary malignancies and systemic toxicity (PubMed, 2022). Consequently, this term is typically used to describe a general mechanism of drug-protein interaction or toxicological reactivity rather than a specific therapeutic target for drug development.
Covalent modification of nucleophilic functional groups (e.g., sulfhydryl, amino, hydroxyl, or imidazole groups) through alkylation, acylation, or coordination by electrophilic drugs or reactive metabolites.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleophilic cellular proteins and peptides.